ISM012-077
/ Insilico Medicine, Dongguan HEC TaiGen Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 18, 2026
A Phase 1 Study of ISM4808 in Healthy Adult Subjects
(clinicaltrials.gov)
- P1 | N=86 | Not yet recruiting | Sponsor: TaiGen Biotechnology Co., Ltd.
New P1 trial
1 to 1
Of
1
Go to page
1